The new report suggests that the global migraine treatment market is coming out with two new pharmaceutical agents and pending drugs that will improve the market moderately over the coming years. The market is estimated to grow from USD 2.5 billion in 2012 to USD 3.7 billion by 2023, recording an annual compound growth rate of 3.6%.

United States remains dominant

As per the research on the migraine market, United States remains dominant with more than 77% market share and is expected to further increase its lead by 2023 reaching up to 84% of the total market. All the new drugs are developed to provide an alternative route of administration to the existing formulations for treating the acute problems involved w ... Read more »

Healthcare reports on brain tumors state that brain tumor arises due to an abnormal development or growth of cells that have multiplied in an uncontrolled manner, rooting from the brain cells. The tumors are classified based on how aggressive they are – wherein lower-grade tumors often are benign while higher-grade tumors are malignant in nature.

When cells grow old or get damaged, they either undergo a programmed cell death (apoptosis) or get repaired naturally within the human body. However, during this process, mutations and alterations can occur in the cellular DNA that disrupt these regulatory processes and consequently cells that would have normally died, go on to survive and proliferate. These cells multiply and ... Read more »